Scientists found that messenger RNA (mRNA) molecules that carry genetic instructions to the far reaches of neurons in the brain tend to cluster together mostly because they are abundant, not because ...
A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to large-scale health studies, to identify adults who could benefit from new drugs, ...
REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the publication in Nature Genetics of ...
EAST GRAND FORKS – After decades of trying to obtain a parcel of land owned by the J.R. Simplot Company, current and former East Grand Forks city officials alike are hopeful that the land exchange ...
DNA sequencing is one of today's most critical scientific fields, powering leaps in humanity's understanding of genetic causes of cancer, neurodegenerative diseases, and diabetes. One issue facing the ...
Wednesday marked the 162nd anniversary of The Gettysburg Address. And while it may feel like “four-score and seven years ago” since the Steelers last won a postseason game, it hasn’t really been that ...
Panelists discuss how integrating real-world evidence into coverage frameworks can enhance decision-making and align payer policies with actual patient outcomes. Panelists discuss how real-world ...
Fintel reports that on November 25, 2025, Piper Sandler initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Overweight recommendation. As of November 17, 2025, the average one-year price target ...
Celebrity Cruises president Laura Hodges Bethge and Royal Caribbean International CEO Michael Bayley at CruiseWorld. Photo Credit: Teri West FORT LAUDERDALE — The portfolios of sibling brands ...
Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA. Human cells that have been edited with the new retron-based gene editing technology. Orange dots mark ...
Fintel reports that on October 16, 2025, Chardan Capital initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Buy recommendation. Analyst Price Forecast Suggests 308.00% Upside As of September 30 ...